A group of researchers has proposed an evaluation framework to assist clinicians in evaluating the utility, safety, and efficacy of smartphone apps for psychiatry.
Based on software engineering, informatics, and clinical knowledge and experiences, a group of researchers has proposed an evaluation framework to assist clinicians in evaluating the utility, safety, and efficacy of smartphone apps for psychiatry.
More than 165,000 healthcare-related mobile apps are currently available, among which the largest category of apps focuses on mental health disorders, covering everything from addiction to depression and schizophrenia. “Evaluating an app requires new considerations that are beyond those employed in evaluating a medication or typical clinical intervention,” write the researchers in a commentary published in The Journal of Clinical Psychiatry.
However, the efficacy of most smartphone apps have not undergone rigorous scientific review, according to commentary co-author Peter Yellowlees, Professor of Psychiatry at the University of California at Davis and an expert in technology use in the clinical setting. “While patients have access to an exponentially increasing number of apps, the research literature has not kept pace,” He said. “But this lack of data has not held back the high level of industry and consumer interest.”
Among this ever-growing collection of mental health-focused apps, only 14 that cover major depressive disorder or bipolar disorder were examined in a recent literature review. Of them, only half had been reviewed for people with psychosis. And for those seven, little efficacy, safety, or clinical outcome data existed in the published literature.
According to Yellowlees and colleagues’ commentary, psychiatrists are left with two options for considering apps and other consumer devices for clinical care:
For those who choose the second option, the team recommends a framework to consider when evaluating all “ASPECTS” of an app: whether the app is Actionable, Secure, Professional, Evidence-Based, Customizable and TranSparent:
“The framework presented here is important, as it offers a flexible tool that clinicians and patients can use together to make more informed decisions about whether to use or not use a smartphone app or other mobile health technology,” said lead author John Torous, a clinical fellow in psychiatry at Beth Israel Deaconess Medical Center and the Harvard Medical School and chair of the American Psychiatry Association Workgroup on Smartphone App Evaluation.. “While both patients and clinicians know the right questions to ask about a new medication or pill, sometimes they may not be aware of all the best questions to ask about an app. With this framework we hope to guide them towards a more informed discussion.”